Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Clinical trial NCT01734850 · COMPLETED

Trial details

NCT number: NCT01734850
Sponsor: Calimmune, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2013-04-01
Primary completion: 2017-09-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.